Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) announced that a poster detailing preliminary results from the Company’s Phase 1A study in healthy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE